VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Healthy pregnant women age 18 to 50                │ Healthy pregnant women age 18 to 50                │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Singleton pregnancy at gestational age 36 weeks or │ Singleton pregnancy at gestational age 36 weeks or │     100 │
│ more                                               │ more                                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Able to read and understand Norwegian              │ Able to read and understand Norwegian              │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with placenta pathology such as praevia,  │ Patients with placenta pathology such as praevia,  │     100 │
│ acreta, pre-eclampsia                              │ acreta, pre-eclampsia                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with bleeding disorders including         │ Patients with bleeding disorders including         │     100 │
│ vonWillebrand disease type I                       │ vonWillebrand disease type I                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Known intolerance to one of the two drugs          │ Known intolerance to one of the two drugs          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with prolonged QT-time or other serious   │ Patients with prolonged QT-time or other serious   │     100 │
│ cardiac diseases                                   │ cardiac diseases                                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Liver or kidney failure                            │ Liver or kidney failure                            │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Epilepsy                                           │ Epilepsy                                           │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any medical reason why, in the opinion of the      │ Any medical reason why, in the opinion of the      │     100 │
│ investigator, the patient should not participate   │ investigator, the patient should not participate   │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤═══════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                         │   Score │
╞═══════════════════════════════════╪═══════════════════════════════════════╪═════════╡
│ Must be FEMALE                    │ Able to read and understand Norwegian │      20 │
├───────────────────────────────────┼───────────────────────────────────────┼─────────┤
│ Must have minimum age of 18 Years │ Healthy pregnant women age 18 to 50   │      41 │
├───────────────────────────────────┼───────────────────────────────────────┼─────────┤
│ Must have maximum age of 50 Years │ Healthy pregnant women age 18 to 50   │      41 │
╘═══════════════════════════════════╧═══════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 92
Average Levenshtein Ratio of individual lines: 84.76923076923077
OverAll Ratio: 88.38461538461539
